NCT04504084

Brief Summary

Ureteral stone is a common disease with high prevalence and recurrence rate in Taiwan. Taiwan is located in subtropical zone, where urolithiasis is commonly seen. A national survey in Taiwan determined that 9.6% of the population suffered stones throughout their lifetime. Symptoms of ureteral stone include renal colic, hematuria, and urinary tract infection. Without proper treatment, ureteral stone could lead to renal function impairment such as acute kidney injury (AKI) or chronic kidney disease (CKD). There are several treatment options for ureteral stone, such as ureteroscopic lithotripsy (URSL), flexible urteroscopic lithotripsy (F-URSL), percutaneous nephrolithotomy (PCNL), extracorporeal shock wave lithotripsy (ESWL), and Medical expulsive therapy (MET). However, there are only few minutes from diagnosis of ureteral stone to possible treatment options explanation. It's difficult for patients to well understand all the details of possible treatments under such circumstances. Therefore, we design a patient decision aid (PDA) for unilateral ureteral stone to help patients understand all the treatment options. The PDA is standardized, written in plain language and patient-centered, with pictures attached.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 7, 2020

Completed
25 days until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

August 7, 2020

Status Verified

August 1, 2020

Enrollment Period

1.3 years

First QC Date

August 5, 2020

Last Update Submit

August 5, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Decision conflicts

    Total score of decisional conflict scale

    For patients choose URSL or F-URSL, one day before the operation. For patients choose ESWL, half an hour before the treatment.

Secondary Outcomes (1)

  • SURE test

    For patients choose URSL or F-URSL, one day before the operation. For patients choose ESWL, half an hour before the treatment.

Study Arms (2)

Decision aid group

EXPERIMENTAL

Shared decision making using decision aid

Other: Decision aid

Controlled group

NO INTERVENTION

Standard oral explanation the details of treament options

Interventions

Patient Decision Aid is a tool that helps patient with ureteral stone become involved in decision making on choosing treatment for ureteral stone. Patient Decision Aid provides information about the options and outcomes, and by clarifying personal values.

Decision aid group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages between 18 and 75
  • Ureteral stone diagnosed with KUB, IVP or CT
  • Stone size between 0 to 2 cm

You may not qualify if:

  • Stone passage spontaneously
  • Patients who do not speak Mandarian
  • Patients with dementia
  • Nationality not Republic of China
  • Patients with bilateral ureteral stone
  • Patients with staghorn stone
  • Patients with bladder stone
  • Patients with severe infection
  • Pregnant women
  • Others patients could not communicate with

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Ureterolithiasis

Interventions

Decision Support Techniques

Condition Hierarchy (Ancestors)

Ureteral DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Yi-Te Chiang, MD

    No.291, Zhongzheng Rd., Zhonghe , Taipei 23561, Taiwan. Shuanghe Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yi-Te Chiang, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2020

First Posted

August 7, 2020

Study Start

September 1, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

August 7, 2020

Record last verified: 2020-08